Stoke Therapeutics
STOK
STOK
100 hedge funds and large institutions have $495M invested in Stoke Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+4
Holders Change %
+4.17%
% of All Funds
1.58%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
42
Reduced
27
Closed
9
Calls
$3.03M
Puts
$177K
Net Calls
+$2.85M
Net Calls Change
+$2.74M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$17.1M |
| 2 |
BlackRock
New York
|
$24.4M |
| 3 |
CAC
Cowen and Company
New York
|
$39.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
$24.7M |
| 5 |
Millennium Management
New York
|
$4.84M |
